|
Clinical Trials and Observations
Citations 251-260 of 2742 total displayed.
|
Past content
(since May 1998):
|
Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab
- Farrukh T. Awan, Neil E. Kay, Melanie E. Davis, Wenting Wu, Susan M. Geyer, Nelson Leung, Diane F. Jelinek, Renee C. Tschumper, Charla R. Secreto, Thomas S. Lin, Michael R. Grever, Tait D. Shanafelt, Clive S. Zent, Timothy G. Call, Nyla A. Heerema, Gerard Lozanski, John C. Byrd, and David M. Lucas
Blood 2009; 113: 535-537.
[Abstract]
[Full text]
[PDF]
Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency
- Éva Ajzner, Ágota Schlammadinger, Adrienne Kerényi, Zsuzsanna Bereczky, Éva Katona, Gizella Haramura, Zoltán Boda, and László Muszbek
Blood 2009; 113: 723-725.
[Abstract]
[Full text]
[PDF]
Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia
- Sarah Cooley, Elizabeth Trachtenberg, Tracy L. Bergemann, Koy Saeteurn, John Klein, Chap T. Le, Steven G. E. Marsh, Lisbeth A. Guethlein, Peter Parham, Jeffrey S. Miller, and Daniel J. Weisdorf
Blood 2009; 113: 726-732.
[Abstract]
[Full text]
[PDF]
Phase I study of obatoclax mesylate (GX15-070), a small molecule pan–Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia
- Susan M. O'Brien, David F. Claxton, Michael Crump, Stefan Faderl, Thomas Kipps, Michael J. Keating, Jean Viallet, and Bruce D. Cheson
Blood 2009; 113: 299-305.
[Abstract]
[Full text]
[PDF]
Thyroid function following hematopoietic cell transplantation in children: 30 years' experience
- Jean E. Sanders, Paul A. Hoffmeister, Ann E. Woolfrey, Paul A. Carpenter, Barry E. Storer, Rainer F. Storb, and Frederick R. Appelbaum
Blood 2009; 113: 306-308.
[Abstract]
[Full text]
[PDF]
TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements
- Hong-Yan Du, Elena Pumbo, Jennifer Ivanovich, Ping An, Richard T. Maziarz, Ulrike M. Reiss, Deborah Chirnomas, Akiko Shimamura, Adrianna Vlachos, Jeffrey M. Lipton, Rakesh K. Goyal, Frederick Goldman, David B. Wilson, Philip J. Mason, and Monica Bessler
Blood 2009; 113: 309-316.
[Abstract]
[Full text]
[PDF]
How we treat a hemophilia A patient with a factor VIII inhibitor
- Christine L. Kempton and Gilbert C. White, II
Blood 2009; 113: 11-17.
[Abstract]
[Full text]
[PDF]
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study
- Massimo Di Nicola, Roberta Zappasodi, Carmelo Carlo-Stella, Roberta Mortarini, Serenella M. Pupa, Michele Magni, Liliana Devizzi, Paola Matteucci, Paola Baldassari, Fernando Ravagnani, Antonello Cabras, Andrea Anichini, and Alessandro M. Gianni
Blood 2009; 113: 18-27.
[Abstract]
[Full text]
[PDF]
Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients
- Mikkael A. Sekeres, Paul Elson, Matt E. Kalaycio, Anjali S. Advani, Edward A. Copelan, Stefan Faderl, Hagop M. Kantarjian, and Elihu Estey
Blood 2009; 113: 28-36.
[Abstract]
[Full text]
[PDF]
A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups
- Sarina Sulong, Anthony V. Moorman, Julie A. E. Irving, Jonathan C. Strefford, Zoe J. Konn, Marian C. Case, Lynne Minto, Kerry E. Barber, Helen Parker, Sarah L. Wright, Adam R. M. Stewart, Simon Bailey, Nick P. Bown, Andrew G. Hall, and Christine J. Harrison
Blood 2009; 113: 100-107.
[Abstract]
[Full text]
[PDF]
|
|
